A detailed history of Janus Henderson Group PLC transactions in Essa Pharma Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 1,006,202 shares of EPIX stock, worth $1.81 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,006,202
Previous 1,175,242 14.38%
Holding current value
$1.81 Million
Previous $9.98 Million 46.96%
% of portfolio
0.0%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$4.63 - $8.42 $782,655 - $1.42 Million
-169,040 Reduced 14.38%
1,006,202 $5.29 Million
Q1 2024

May 15, 2024

BUY
$6.17 - $10.65 $529,139 - $913,344
85,760 Added 7.87%
1,175,242 $9.98 Million
Q4 2023

Feb 14, 2024

BUY
$2.74 - $7.35 $2.99 Million - $8.01 Million
1,089,482 New
1,089,482 $7.19 Million
Q2 2022

Aug 15, 2022

SELL
$3.15 - $7.94 $1.77 Million - $4.47 Million
-563,390 Reduced 16.22%
2,909,410 $9.17 Million
Q1 2022

May 16, 2022

BUY
$6.18 - $14.44 $420,814 - $983,262
68,093 Added 2.0%
3,472,800 $21.5 Million
Q4 2021

Feb 14, 2022

SELL
$7.8 - $14.38 $570,468 - $1.05 Million
-73,137 Reduced 2.1%
3,404,707 $48.3 Million
Q3 2021

Nov 16, 2021

BUY
$7.76 - $29.37 $11.3 Million - $42.9 Million
1,459,950 Added 72.35%
3,477,844 $27.8 Million
Q2 2021

Aug 16, 2021

BUY
$24.17 - $34.28 $12.1 Million - $17.2 Million
501,792 Added 33.1%
2,017,894 $57.7 Million
Q1 2021

May 17, 2021

BUY
$11.61 - $32.08 $11.7 Million - $32.3 Million
1,007,007 Added 197.8%
1,516,102 $44 Million
Q4 2020

Feb 16, 2021

BUY
$5.47 - $12.1 $182,736 - $404,224
33,407 Added 7.02%
509,095 $6 Million
Q3 2020

Nov 16, 2020

BUY
$6.0 - $7.79 $444,552 - $577,176
74,092 Added 18.45%
475,688 $3.26 Million
Q2 2020

Aug 14, 2020

BUY
$3.71 - $6.2 $752,376 - $1.26 Million
202,797 Added 102.01%
401,596 $2.46 Million
Q1 2020

May 14, 2020

BUY
$3.23 - $5.87 $642,120 - $1.17 Million
198,799 New
198,799 $796,000

Others Institutions Holding EPIX

About ESSA Pharma Inc.


  • Ticker EPIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,073,100
  • Market Cap $79.3M
  • Description
  • ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...
More about EPIX
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.